Keyword: Dr. Reddy’s

Strategy & Management

Facing Strong Headwinds

14.09.2020 -

So far, the pharmaceutical industry — including CMOs/CDMOs — has responded well to the outbreak of the Covid-19 pandemic.

News

US States Sue Drugmakers Over Price-fixing

15.05.2019 - A coalition of 44 US states has filed a 500-page lawsuit against 20 leading generic drugmakers supplying the domestic market. The companies are accused of operating a sweeping...

News

Dr. Reddy’s in Fresh Asset Sale

17.10.2018 - India’s Dr. Reddy's Laboratories has entered a definitive agreement to sell its API manufacturing business unit at Jeedimetla, Hyderabad, to Therapiva Private Ltd, an emerging...

Plant Construction & Process Technology

Setting High Standards

28.09.2017 - Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. How big of an issue is a merger or an acquisition for...

Plant Construction & Process Technology

M&A in Pharma and CRO/CMO Industry

28.09.2017 - Challenges caused by a merger or an acquisition can be manifold, no matter whether it is your own organization that is going through M&A and the integration phase or any of your...

Strategy & Management

CPhI 2014 Experts Statements: Christian Jones, Associate Director — Business Development, Dr. Reddy’s

01.10.2014 - 1. What roles do contract research organizations (CROs) and contract manufacturing organizations (CMOs) play in the drug discovery/development value chain today, and how will their...

Strategy & Management

Today’s Challenges, Tomorrow’s Excellence

01.10.2014 - Pharmaceutical companies have outsourced several critical steps in the discovery and development of new drugs and the scale-up of processes and the manufacturing of APIs. Pharma...

Markets & Companies

Potential In Eastern Europe

29.07.2014 - Over the past five years, emerging markets have experienced some of the highest pharmaceutical market growth rates, a trend that is expected to continue. Central Eastern Europe...